0001171843-19-000064.txt : 20190103 0001171843-19-000064.hdr.sgml : 20190103 20190103081932 ACCESSION NUMBER: 0001171843-19-000064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190103 DATE AS OF CHANGE: 20190103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eldridge, George Arthur CENTRAL INDEX KEY: 0001622905 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 19503679 BUSINESS ADDRESS: STREET 1: 64 DAMIEN ROAD CITY: WELLESLEY STATE: MA ZIP: 02481 BUSINESS PHONE: 617-290-9883 MAIL ADDRESS: STREET 1: 64 DAMIEN ROAD CITY: WELLESLEY STATE: MA ZIP: 02481 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml X0306 4 2018-12-31 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001622905 Eldridge, George Arthur C/O PROTEON THERAPEUTICS 200 WEST STREET WALTHAM MA 02451 0 1 0 0 Sr VP, CFO, Treasr, Asst Secy Common Stock 2018-12-31 5 A 0 E 2448 1.93 A 29132 D Common Stock 1545 I See footnote The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). These securities were purchased by the reporting person as custodian for three minor children under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. /s/ George A. Eldridge 2019-01-03